These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 31229653)
21. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency. Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039 [TBL] [Abstract][Full Text] [Related]
22. Junction site analysis of chimeric CYP21A1P/CYP21A2 genes in 21-hydroxylase deficiency. Chen W; Xu Z; Sullivan A; Finkielstain GP; Van Ryzin C; Merke DP; McDonnell NB Clin Chem; 2012 Feb; 58(2):421-30. PubMed ID: 22156666 [TBL] [Abstract][Full Text] [Related]
23. Comparing the Southern blot method and polymerase chain reaction product analysis for chimeric RCCX detection in CYP21A2 deficiency. Lee HH; Lee YJ; Chao MC Anal Biochem; 2010 Apr; 399(2):293-8. PubMed ID: 19961824 [TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of the new clinical entity associated with congenital adrenal hyperplasia: the CAH-X syndrome in the Spanish population. Figueras LM; Pacheco RM; González DG; Domènech MA; Zubicaray BE Adv Lab Med; 2023 Sep; 4(3):258-267. PubMed ID: 38075167 [TBL] [Abstract][Full Text] [Related]
25. A new CYP21A1P/CYP21A2 chimeric gene identified in an Italian woman suffering from classical congenital adrenal hyperplasia form. Concolino P; Mello E; Minucci A; Giardina E; Zuppi C; Toscano V; Capoluongo E BMC Med Genet; 2009 Jul; 10():72. PubMed ID: 19624807 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-β (TGF-β) pathway abnormalities in tenascin-X deficiency associated with CAH-X syndrome. Morissette R; Merke DP; McDonnell NB Eur J Med Genet; 2014 Feb; 57(2-3):95-102. PubMed ID: 24380766 [TBL] [Abstract][Full Text] [Related]
27. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Chen W; Kim MS; Shanbhag S; Arai A; VanRyzin C; McDonnell NB; Merke DP Am J Med Genet A; 2009 Dec; 149A(12):2803-8. PubMed ID: 19921645 [TBL] [Abstract][Full Text] [Related]
28. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Lee HH; Lee YJ; Lin CY Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125 [TBL] [Abstract][Full Text] [Related]
29. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880 [TBL] [Abstract][Full Text] [Related]
30. Congenital adrenal hyperplasia due to two rare CYP21A2 variant alleles, including a novel attenuated CYP21A1P/CYP21A2 chimera. Lao Q; Burkardt DD; Kollender S; Faucz FR; Merke DP Mol Genet Genomic Med; 2023 Jul; 11(7):e2195. PubMed ID: 37157918 [TBL] [Abstract][Full Text] [Related]
31. Improved Genetic Characterization of Congenital Adrenal Hyperplasia by Long-Read Sequencing Compared with Multiplex Ligation-Dependent Probe Amplification Plus Sanger Sequencing. Yuan D; Cai R; Mao A; Tan J; Zhong Q; Zeng D; Tang N; Wei X; Huang J; Zhang Y; Chen D; Yang J; Li Y; Zheng X; Li J; Li D; Yan T J Mol Diagn; 2024 Sep; 26(9):770-780. PubMed ID: 38925455 [TBL] [Abstract][Full Text] [Related]
32. Response to Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". Marino R; Perez Garrido N; Ramirez P; Belgorosky A J Clin Endocrinol Metab; 2021 Jun; 106(7):e2837-e2838. PubMed ID: 33901286 [No Abstract] [Full Text] [Related]
33. Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clirnical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". Lao Q; Merke DP J Clin Endocrinol Metab; 2021 Jun; 106(7):e2835-e2836. PubMed ID: 33901292 [No Abstract] [Full Text] [Related]
35. Unusual Combination of MEN-1 and the Contiguous Gene Deletion Syndrome of CAH and Ehlers-Danlos Syndrome (CAH-X). Chen Cardenas SM; El-Kaissi S; Jarad O; Liaqat M; Korbonits M; Hamrahian AH J Endocr Soc; 2020 Aug; 4(8):bvaa077. PubMed ID: 32715272 [TBL] [Abstract][Full Text] [Related]
36. Congenital adrenal hyperplasia, ovarian failure and Ehlers-Danlos syndrome due to a 6p deletion. Moysés-Oliveira M; Mancini TI; Takeno SS; Rodrigues AD; Bachega TA; Bertola D; Melaragno MI Sex Dev; 2014; 8(4):139-45. PubMed ID: 24970489 [TBL] [Abstract][Full Text] [Related]
37. Recurrent pneumothorax in a case of tenascin-X deficient Ehlers-Danlos syndrome: Broadening the phenotypic spectrum. Santoreneos R; Vakulin C; Ellul M; Rawlings L; Hardy T; Poplawski N Am J Med Genet A; 2022 May; 188(5):1583-1588. PubMed ID: 35128805 [TBL] [Abstract][Full Text] [Related]
38. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569 [TBL] [Abstract][Full Text] [Related]
39. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions. Koppens PF; Hoogenboezem T; Degenhart HJ Hum Mol Genet; 2002 Oct; 11(21):2581-90. PubMed ID: 12354783 [TBL] [Abstract][Full Text] [Related]
40. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease. Carrozza C; Foca L; De Paolis E; Concolino P Front Endocrinol (Lausanne); 2021; 12():709758. PubMed ID: 34394006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]